| Amyloid β deposition, neurodegeneration, and cognitive decline in sporadic Alzheimer's disease: a prospective cohort study VL Villemagne, S Burnham, P Bourgeat, B Brown, KA Ellis, O Salvado, ... The Lancet Neurology 12 (4), 357-367, 2013 | 2544* | 2013 |
| Amyloid imaging results from the Australian Imaging, Biomarkers and Lifestyle (AIBL) study of aging CC Rowe, KA Ellis, M Rimajova, P Bourgeat, KE Pike, G Jones, J Fripp, ... Neurobiology of aging 31 (8), 1275-1283, 2010 | 1144 | 2010 |
| Longitudinal assessment of Aβ and cognition in aging and Alzheimer disease VL Villemagne, KE Pike, G Chételat, KA Ellis, RS Mulligan, P Bourgeat, ... Annals of neurology 69 (1), 181-192, 2011 | 1038 | 2011 |
| Relationship between atrophy and β‐amyloid deposition in Alzheimer disease G Chételat, VL Villemagne, P Bourgeat, KE Pike, G Jones, D Ames, ... Annals of neurology 67 (3), 317-324, 2010 | 462 | 2010 |
| Retinal vascular biomarkers for early detection and monitoring of Alzheimer’s disease S Frost, Y Kanagasingam, H Sohrabi, J Vignarajan, P Bourgeat, ... Translational psychiatry 3 (2), e233-e233, 2013 | 335 | 2013 |
| Regional dynamics of amyloid-β deposition in healthy elderly, mild cognitive impairment and Alzheimer’s disease: a voxelwise PiB–PET longitudinal study N Villain, G Chételat, B Grassiot, P Bourgeat, G Jones, KA Ellis, D Ames, ... Brain 135 (7), 2126-2139, 2012 | 300 | 2012 |
| Ea-GANs: edge-aware generative adversarial networks for cross-modality MR image synthesis B Yu, L Zhou, L Wang, Y Shi, J Fripp, P Bourgeat IEEE transactions on medical imaging 38 (7), 1750-1762, 2019 | 283 | 2019 |
| Cerebral quantitative susceptibility mapping predicts amyloid-β-related cognitive decline S Ayton, A Fazlollahi, P Bourgeat, P Raniga, A Ng, YY Lim, I Diouf, ... Brain 140 (8), 2112-2119, 2017 | 267 | 2017 |
| β-Amyloid burden in the temporal neocortex is related to hippocampal atrophy in elderly subjects without dementia P Bourgeat, G Chetelat, VL Villemagne, J Fripp, P Raniga, K Pike, ... Neurology 74 (2), 121-127, 2010 | 259 | 2010 |
| Predicting Alzheimer disease with β‐amyloid imaging: results from the Australian imaging, biomarkers, and lifestyle study of ageing CC Rowe, P Bourgeat, KA Ellis, B Brown, YY Lim, R Mulligan, G Jones, ... Annals of neurology 74 (6), 905-913, 2013 | 258 | 2013 |
| Clinical and cognitive trajectories in cognitively healthy elderly individuals with suspected non-Alzheimer's disease pathophysiology (SNAP) or Alzheimer's disease pathology: a … SC Burnham, P Bourgeat, V Doré, G Savage, B Brown, S Laws, P Maruff, ... The Lancet Neurology 15 (10), 1044-1053, 2016 | 233 | 2016 |
| Subjective memory decline predicts greater rates of clinical progression in preclinical Alzheimer's disease RF Buckley, P Maruff, D Ames, P Bourgeat, RN Martins, CL Masters, ... Alzheimer's & Dementia 12 (7), 796-804, 2016 | 223 | 2016 |
| Cross-sectional and longitudinal analysis of the relationship between Aβ deposition, cortical thickness, and memory in cognitively unimpaired individuals and in Alzheimer disease V Doré, VL Villemagne, P Bourgeat, J Fripp, O Acosta, G Chetélat, L Zhou, ... JAMA neurology 70 (7), 903-911, 2013 | 217 | 2013 |
| Larger temporal volume in elderly with high versus low beta-amyloid deposition G Chételat, VL Villemagne, KE Pike, JC Baron, P Bourgeat, G Jones, ... Brain 133 (11), 3349-3358, 2010 | 180* | 2010 |
| Larger temporal volume in asymptomatic elderly with high versus low beta-amyloid deposition G Chetelat, V Villemagne, K Pike, JC Baron, P Bourgeat, G Jones, K Ellis, ... Alzheimer's & Dementia: The Journal of the Alzheimer's Association 6 (4), S2-S3, 2010 | 173* | 2010 |
| Lesion segmentation from multimodal MRI using random forest following ischemic stroke J Mitra, P Bourgeat, J Fripp, S Ghose, S Rose, O Salvado, A Connelly, ... NeuroImage 98, 324-335, 2014 | 165 | 2014 |
| Aβ-amyloid and tau imaging in dementia VL Villemagne, V Dore, P Bourgeat, SC Burnham, S Laws, O Salvado, ... Seminars in nuclear medicine 47 (1), 75-88, 2017 | 162 | 2017 |
| BDNF Val66Met, Aβ amyloid, and cognitive decline in preclinical Alzheimer's disease YY Lim, VL Villemagne, SM Laws, D Ames, RH Pietrzak, KA Ellis, ... Neurobiology of aging 34 (11), 2457-2464, 2013 | 149 | 2013 |
| 3D cGAN based cross-modality MR image synthesis for brain tumor segmentation B Yu, L Zhou, L Wang, J Fripp, P Bourgeat 2018 IEEE 15th international symposium on biomedical imaging (ISBI 2018 …, 2018 | 146 | 2018 |
| Comparison of MR-less PiB SUVR quantification methods P Bourgeat, VL Villemagne, V Dore, B Brown, SL Macaulay, R Martins, ... Neurobiology of aging 36, S159-S166, 2015 | 138 | 2015 |
Christopher Cleon RoweUniversity of MelbourneEmail verificata su austin.org.au
